612 related articles for article (PubMed ID: 19618757)
21. Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease.
Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
Hypertension; 2009 Sep; 54(3):e19-20. PubMed ID: 19652085
[No Abstract] [Full Text] [Related]
22. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
[TBL] [Abstract][Full Text] [Related]
23. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
Weir MR
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
[TBL] [Abstract][Full Text] [Related]
24. [Renoprotective effects of antihypertensives].
Monhart V
Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
[TBL] [Abstract][Full Text] [Related]
25. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
Bakris GL; Weir MR
Postgrad Med; 2008 Apr; 120(1):33-42. PubMed ID: 18467807
[TBL] [Abstract][Full Text] [Related]
26. [Dual blockade of the renin-angiotensin system].
Andersen NH; Mogensen CE
Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
[No Abstract] [Full Text] [Related]
27. Time for a comeback of NSAIDs in proteinuric chronic kidney disease?
Vogt L; Laverman GD; Navis G
Neth J Med; 2010 Dec; 68(12):400-7. PubMed ID: 21209465
[TBL] [Abstract][Full Text] [Related]
28. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
Johnston CI; Fabris B; Jandeleit K
Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
[TBL] [Abstract][Full Text] [Related]
29. Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
Okamoto T
Int J Mol Med; 2003 May; 11(5):651-4. PubMed ID: 12684706
[TBL] [Abstract][Full Text] [Related]
30. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
Adzhienko LM
Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
[No Abstract] [Full Text] [Related]
31. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
Karlsen FM; Kamper AL
Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
[No Abstract] [Full Text] [Related]
32. Blood pressure, proteinuria and nephropathy in Fabry disease.
Jain G; Warnock DG
Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
[TBL] [Abstract][Full Text] [Related]
33. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
Bhandari S; Mehta S; Khwaja A; Cleland JGF; Ives N; Brettell E; Chadburn M; Cockwell P;
N Engl J Med; 2022 Dec; 387(22):2021-2032. PubMed ID: 36326117
[TBL] [Abstract][Full Text] [Related]
34. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
Boos CJ; Lip GY
J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
[No Abstract] [Full Text] [Related]
35. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Weir MR
Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
37. The incidence and implications of aldosterone breakthrough.
Bomback AS; Klemmer PJ
Nat Clin Pract Nephrol; 2007 Sep; 3(9):486-92. PubMed ID: 17717561
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases.
Weinberger MH; Luft FC
Kidney Int; 2006 Dec; 70(12):2051-3. PubMed ID: 17136130
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren combined with losartan in diabetes and nephropathy.
Anderson S; Komers R
N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
[No Abstract] [Full Text] [Related]
40. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
Onuigbo MA
Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
